|
< 1 min reading time
There are rumours of potential changes to the FDA approval process particularly geared at devices processed through the 510(k) pathway. Will these changes affect reimbursement strategies? If so, how? Marked as spam
 Posted by Asked on February 10, 2019 5:51 pm
166 views
|
The Medical Devices Group | Copyright © Terms, Conditions & Privacy
